CAS: 210169-54-3; (S)-5,5'-Bis(Diphenylphosphino)-4,4'-Bi-1,3-Benzodioxole

该化合物是用于非对称催化的常用的手性软骨,该复合体具有双-1,3-苯二氧基骨,有助于其独特的结构特性和消毒环境;两个二苯基磷基组的存在增强了其与过渡金属协调的能力,使其有效地促进各种化学反应,特别是形成碳-碳联结;离心能允许选择性地生产对应性丰富产品,这对合成药品和精密化学品至关重要;此外,其有机溶剂的稳定性和溶解性使其适合一系列催化应用;

结构式图片

上下游产品

(+/-)-(4,4'-Bi-1,3-Benzodioxole)-5,5'-Diyl-Bis(Diphenylphosphine Oxide)

合成工艺路线路线简述

    Benzo[d][1,3]Dioxol-5-Yldiphenylphosphine Oxide置于titanium(Iv) Isopropylate,乙二醇二甲醚,酞菁钴,四(二甲氨基)乙烯,(S)-4-叔丁基-2-(2-氮苯基)恶唑啉,Lithium Diisopropyl Amide体系中,用 四氢呋喃,1,4-二氧六环,正己烷 用作溶剂,化学反应 50.0H,反应生成(S)-(-)-5,5-双(二苯膦基)-4,4-双-1,3-苯并间二氧杂环戊烯
    参考文献:通过镍催化不对称 Ullmann 耦合合成轴向手性 2,2'-双磷酸二烯:在没有光学分辨率的情况下获得特权手性配体的一般途径
    标题:通过镍催化不对称 Ullmann 耦合合成轴向手性 2,2'-双磷酸二烯:在没有光学分辨率的情况下获得特权手性配体的一般途径
    摘要:我们报告了邻-(碘) 芳基膦氧化物和邻-(碘) 芳基膦酸盐的不对称同源偶联,导致高度对映体富集的轴向手性双膦氧化物和双膦酸盐.这些产品很容易转化为对映体富集的联芳基双膦,无需手性助剂或光学拆分.这为开发以前未研究的阻转选择性联芳基双膦配体提供了一条实用的途径.这些条件也被证明对其他不含磷的芳基卤化物的不对称二聚化有效.
    Doi:10.1021/jacs.0C12843

    海关参考信息

    专利信息


    专利号:US-11999757-B2
    优先权日:2017-11-01
    标 题:Synthesis of boronate ester derivatives and uses thereof
    发明人:BOYER SERGE HENRI; HECKER SCOTT J; VERZIJL GERARDUS K M; HERMSEN PETRUS J
    权利人:MELINTA SUBSIDIARY CORP
    摘要:Disclosed herein are methods for the preparation of boronate derivatives in the synthesis of antimicrobial compounds and uses thereof. Disclosed herein includes method of making a compound of Formula (B) by reducing the ketone group of the keto-ester compound of Formula (A), and the reduction can be performed using a Ruthenium based catalyst system or using an alcohol dehydrogenase bioreduction system.

    专利号:US-2025101006-A1
    优先权日:2022-01-31
    标题:Process for the synthesis of pyrazolyl derivatives useful as anti-cancer agents
    发明人:BAENZIGER MARKUS; GALLOU FABRICE; GUO FENGFENG; HÄNGGI RUDOLF; HAN ENJIAN; JORDINE GUIDO; LI JIALIANG; LIU WEIPENG; MIAO BUKEYAN; RONG SHAOFENG; SANTANDREA ERNESTO; SCHIRNER PAUL BERND; SHEN XIAODONG; WANG CAN; ZHANG HAO
    权利人:NOVARTIS AG
    摘要:The invention provides a novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially KRAS G12C inhibitors. The present invention provides a direct enantioselective chemical manufacturing method of making Compound A, or a pharmaceutically acceptable hydrate or solvent thereof: (I). The invention provides a process for preparing Intermediate B6* comprising reacting Intermediate B4* with Intermediate B5* in an atroposelective coupling reaction, using a chiral catalyst.

    专利号:US-10745354-B2
    优先权日:2017-11-01
    标题 :Methods for enantioselective allylic alkylation of esters, lactones, and lactams with unactivated allylic alcohols
    发明人:STOLTZ BRIAN M; NGAMNITHIPORN AURAPAT; JETTE CARINA I; BACHMAN SHOSHANA; VIRGIL SCOTT C; LACKNER SEBASTIAN
    权利人:CALIFORNIA INST OF TECHN
    摘要:The present disclosure provides methods for enantioselective synthesis of cyclic and acyclic α-quaternary carboxylic acid derivatives via nickel-catalyzed allylic alkylation.

    专利号:US-8729306-B2
    优先权日:2010-02-05
    标 题:Process for the preparation of nitrogen substituted aminotetralins derivatives
    发明人:VASSELIN DAVID; CARLY NICOLAS; ATES CELAL
    权利人:VASSELIN DAVID; CARLY NICOLAS; ATES CELAL; UCB PHARMA GMBH
    摘要:The present invention provides an alternative synthesis of N-substituted aminotetralines which synthesis comprises catalytic asymmetric hydrogenation of compounds of general formula (A).

    专利号:US-2022064111-A1
    优先权日:2019-01-17
    标 题:Enantioselective synthesis of brivaracetam and intermediates thereof
    发明人:ROY SARABINDU; GHOSH ANGSHUMAN; KUBEER RAMESH DHONDI; PRASAD MUTYALA V V VARA; PAUL GOPAL; GARAI ABHISHEK; CHAKRABORTY SOURAV; HALDAR ANIMESH; YADAW AJAY KUMAR; ROY SUBHO
    权利人:CLININVENT RES PVT LTD
    摘要:The present invention relates to an improved and economical process for enantioselective synthesis and purification of a novel key intermediate of Brivaracetam. Further, the present invention also relates to a process for the preparation of a chirally pure Brivaracetam of formula I utilizing the said intermediate.

    专利号:US-2024199569-A1
    优先权日:2022-11-30
    标 题:Process for the manufacture of inhibitors of kras
    发明人:ZHANG YONGDA; CHONG EUGENE; REEVES JONATHAN TIMOTHY; WHITE JADA A H; LEI ZHEN
    权利人:BOEHRINGER INGELHEIM INT
    摘要:This invention relates to an efficient and enantioselective synthesis of the spiro-compounds of formula (1) as common intermediate, featuring an asymmetric introduction of the all-carbon quaternary centre in high selectivity and a very efficient one-pot procedure for the C2 elongation to generate the spiro-structure.For the all-carbon quaternary centre, a Tsuji-Trost asymmetric allylic alkylation (AAA) process was designed to develop a sustainable procedure with very low catalyst loading, thereby also facilitating the Pd content control in the product, under practically solvent free conditions. Furthermore, multiple synthetic transformations in a one-pot procedure were implemented by using a one-pot procedure either in form of a three-transformation sequence comprising Hydroboration-Alkylation-Dieckmann Condensation to compound of formula (1) or in form of a five-transformation sequence comprising Hydroboration-Alkylation-Dieckmann Condensation-Hydrolysis-Decarboxylation to compound of formula (9).
    郑州金一化工科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.kingorgchem.com
    企业联系电话:18625597674👤
    📞郑州金一化工科技有限公司 ⚠️参考联系方式
    联系人:陈经理
    电话:18625597674
    手机:18625597674

    邮箱:sales@kingorgchem.com
    通信地址: 河南省郑州市金水区红专路56号
    邮编: 450003
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:河南省郑州市金水区红专路56号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    武汉弘德悦欣医药科技有限公司
    小微企业
    信用代码: 91420102MA4K4WB79G法定代表人:袁洪杰
    注册资本:180万(元)企业类型:有限责任公司(自然人投资或控股)
    成立日期:2019-07-31登记机关:武汉市江岸区市场监督管理局
    注册地址: 武汉市江岸区车站路6号怡东大厦19层F室
    医药、生物工程、生物制品的技术开发、技术服务;医药中间体、化学助剂及化工产品(不含化学危险品)的销售。(依法须经审批的项目,经相关部门审批后方可开展经营活动)
    免费会员展台
    http://www.hongdepharma.com
    企业联系电话:027-83855396👤
    📞 山东昱轩化工产品有限公司
    产品销售经理: 吴经理
    手机: 13657260109
    邮件: 2143879032@qq.com
    ⚠️ 声明: 咨询或交易时请注意风险评估和信息核实,百琢研不参与任何交易。

    地址: 武汉市江岸区车站路6号怡东大厦19层F室
    常规和库存产品*产品总量: 509

    平台资质认证✓营业执照✓
    (S)-(-)-5,5'-双(二苯基磷)-4,4'-二-1,3-苯并二氧
    (S)-(-)-5,5'-Bis(diphenylphosphino)-4,4'-bi-1,3-benzodioxole [(S)-Segphos
    产品图片纯度:98
    250kg/drum
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Spivey, A. C.; Tseng, C.-C., Science of Synthesis Knowledge Updates, (2010) 1, 63.
    摘要:Nahra, F.; Riant, O., Science of Synthesis Knowledge Updates, (2013) 2, 210.
    摘要:Krause, N.; Arisetti, N., Science of Synthesis Knowledge Updates, (2020) 3, 100.
    摘要:Spitzner, D., Science of Synthesis Knowledge Updates, (2016) 1, 36.
    摘要:Tymoshenko, D. O., Science of Synthesis Knowledge Updates, (2012) 3, 377.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知